| Primary |
| Product Used For Unknown Indication |
67.6% |
| Anaemia |
17.6% |
| Intentional Overdose |
2.9% |
| Iron Deficiency |
2.9% |
| Iron Deficiency Anaemia |
2.9% |
| Pain |
2.9% |
| Thrombosis Prophylaxis |
2.9% |
|
| Medication Error |
10.0% |
| Suicide Attempt |
10.0% |
| Death |
5.0% |
| Dyspnoea |
5.0% |
| Faeces Discoloured |
5.0% |
| Hypotension |
5.0% |
| Malabsorption |
5.0% |
| Melaena |
5.0% |
| Muscle Spasms |
5.0% |
| Otorrhoea |
5.0% |
| Product Quality Issue |
5.0% |
| Product Substitution Issue |
5.0% |
| Respiratory Acidosis |
5.0% |
| Scab |
5.0% |
| Slow Response To Stimuli |
5.0% |
| Small Intestinal Obstruction |
5.0% |
| Vomiting |
5.0% |
| Vomiting Projectile |
5.0% |
|
| Secondary |
| Product Used For Unknown Indication |
54.9% |
| Hypertension |
5.6% |
| Breast Cancer |
5.1% |
| Foetal Exposure Timing Unspecified |
4.1% |
| Anaemia |
3.6% |
| Prophylaxis Against Transplant Rejection |
3.6% |
| Drug Exposure During Pregnancy |
3.1% |
| Drug Use For Unknown Indication |
2.6% |
| Diabetes Mellitus |
2.1% |
| Psychotic Disorder |
2.1% |
| Chronic Obstructive Pulmonary Disease |
1.5% |
| Hepatitis C |
1.5% |
| Hyperparathyroidism |
1.5% |
| Infection |
1.5% |
| Schizophrenia |
1.5% |
| Urinary Tract Infection |
1.5% |
| Aggression |
1.0% |
| Colorectal Cancer |
1.0% |
| Dementia Alzheimer's Type |
1.0% |
| Dyslipidaemia |
1.0% |
|
| Vomiting |
15.6% |
| Rash |
11.1% |
| Premature Baby |
8.9% |
| Swollen Tongue |
8.9% |
| Pulmonary Valve Stenosis |
6.7% |
| Therapeutic Product Contamination |
6.7% |
| Maternal Exposure During Pregnancy |
4.4% |
| Overdose |
4.4% |
| Transient Ischaemic Attack |
4.4% |
| Urinary Tract Infection |
4.4% |
| Visual Impairment |
4.4% |
| Chronic Obstructive Pulmonary Disease |
2.2% |
| Decreased Appetite |
2.2% |
| Drug Hypersensitivity |
2.2% |
| Foetal Growth Restriction |
2.2% |
| Gastrointestinal Inflammation |
2.2% |
| Haematoma |
2.2% |
| Hallucination |
2.2% |
| Hepatitis Cholestatic |
2.2% |
| Horner's Syndrome |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
51.6% |
| Drug Use For Unknown Indication |
9.3% |
| Hypertension |
4.9% |
| Pain |
4.3% |
| Rheumatoid Arthritis |
3.1% |
| Anaemia |
3.0% |
| Crohn's Disease |
2.7% |
| Depression |
2.3% |
| Diabetes Mellitus |
2.1% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Osteoporosis |
1.7% |
| Hiv Infection |
1.6% |
| Drug Exposure During Pregnancy |
1.6% |
| Prophylaxis |
1.6% |
| Pulmonary Arterial Hypertension |
1.6% |
| Atrial Fibrillation |
1.6% |
| Anxiety |
1.5% |
| Nausea |
1.2% |
| Type 2 Diabetes Mellitus |
1.2% |
| Constipation |
1.2% |
|
| Vomiting |
14.7% |
| Weight Decreased |
11.8% |
| Pulmonary Embolism |
7.4% |
| Death |
5.9% |
| Pneumonia |
5.9% |
| Renal Failure Acute |
5.6% |
| Weight Increased |
5.6% |
| Urinary Tract Infection |
5.5% |
| Pain |
4.5% |
| Thrombocytopenia |
3.8% |
| Renal Failure |
3.5% |
| Pyrexia |
3.4% |
| Syncope |
3.3% |
| Nausea |
3.2% |
| Sepsis |
3.2% |
| Thrombosis |
2.8% |
| Vision Blurred |
2.6% |
| Myocardial Infarction |
2.5% |
| Tremor |
2.5% |
| Crohn's Disease |
2.4% |
|
| Interacting |
| Product Used For Unknown Indication |
100.0% |
|
|
